SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 1

The effectiveness of serum amyloid A for prediction of neonatal cholestasis associated with parenteral nutrition in premature infants

Hilal ÖZKAN
Nilgün KÖKSAL
Pelin DOĞAN
İpek Güney VARAL
Onur BAĞCI
Taner ÖZGÜR
Pages
26–33
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggestthat SAA may be used as an accurate and useful biomarker for predictionof PNAC in high risk premature infants receiving PN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Parenteral nutrition (PN) has been widely used in premature infants untillenteral feeding can be tolerated.
📊
Key Findings & Data:We also aimed to determinethe risk factors for PN associated cholestasis (PNAC).Premature infants (<34 weeks’ gestational age) who were started on PNduring hospitalization were included in this prospective study.
💡
Conclusion & Impact:We suggestthat SAA may be used as an accurate and useful biomarker for predictionof PNAC in high risk premature infants receiving PN.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Parenteral nutrition (PN) has been widely used in premature infants untillenteral feeding can be tolerated. Cholestasis is an important complication ofPN. The objective of this study was to evaluate the role of serial measurementsof serum amyloid A (SAA) during PN and compare its’ effectiveness withC-reactive protein (CRP) and procalcitonin (PCT). We also aimed to determinethe risk factors for PN associated cholestasis (PNAC).Premature infants (<34 weeks’ gestational age) who were started on PNduring hospitalization were included in this prospective study. SAA, CRP andPCT levels were measured on days 0, 3, 7, 14, and 21 of PN in all infants.Infants who had PN for less than 2 weeks, who developed sepsis and/ornecrotizing enterocolitis were excluded.A total of 85 infants were included. The mean birth weight was 1226±329g, and the mean gestational age was 29.4±1.8 weeks. The birth weight ofinfants who developed cholestasis were significantly lower. Enteral nutritionwas started significantly later in infants with cholestasis. CRP and PCT didnot correlate with conjugated bilirubin levels at any time point. SAA levelson days 7 and 14 showed a significant correlation with conjugated bilirubinlevels. SAA levels on day 7 was found to have the highest sensitivity forprediction of PNAC.Low birth weight, late commencement of enteral feeding, and prolonged PNwere the main risk factors for PNAC development. This is the first studythat shows the predictive value of SAA for PNAC development. We suggestthat SAA may be used as an accurate and useful biomarker for predictionof PNAC in high risk premature infants receiving PN.

🔖

Cite This Article

ÖZKAN, H., KÖKSAL, N., DOĞAN, P., VARAL, İ. G., BAĞCI, O., ÖZGÜR, T. (2019). The effectiveness of serum amyloid A for prediction of neonatal cholestasis associated with parenteral nutrition in premature infants. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 1, 26–33. https://ajindex.com/articles/412032

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutritionassociated liver disease. J Perinatol 2007; 27: 284-290
  2. Hsieh MH, Pai W, Tseng HI, Yang SN, Lu CC, Chen HL. Parenteral nutrition-associated cholestasis in prematüre babies: risk factors and predictors. Pediatr Neonatol 2009; 50: 202-207
  3. Klein CJ, Ravenis M, Kusenda C, Scavo L. Parenteral Nutrition–Associated Conjugated Hyperbilirubinemia in Hospitalized Infants. J Am Diet Assoc 2010; 110: 1684-1695
  4. Robinson DT, Ehrenkranz RA. Parenteral nutritionassociated cholestasis in small for gestational age infants. J Pediatr 2008; 152: 59-62
  5. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118: 197-201
  6. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsion in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000; 24: 345-350
  7. Kurvinen A, Nissinen MJ, Andersson S, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012; 54: 803-811
  8. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant 2010; 15: 330-333
  9. Kosters A, Karpen SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010; 30: 186-194
  10. DeMauro SB, Kilpatrick LE, Gerdes JS, Abbasi S. Early inflammatory markers for prediction of cholestasis in very-low-birth-weight nfants. Neonatology 2012; 102: 229-234
  11. Koksal N, Harmancı R, Cetinkaya M, Hacımustafaoğlu M. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis. Turk J Pediatr 2007; 49: 21-29
  12. Cetinkaya M, Ozkan H, Koksal N, Solmaz Ç, Hacımustafaoğlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol 2009; 29: 225-231
  13. Korczowski B. Serum procalcitonin concentration in children with liver disease. Pediatr Infect Dis J 2006; 25: 268-269
  14. Malle E, Steinmetz A, Raynes JG. An acute phase protein and apolipoprotein. Atherosclerosis 1993; 102: 131-146
  15. Arnon S, Litmanovitz I, Rege